Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tuberous Sclerosis 1Sleep Wake Disorders 1Pancreatic Neoplasms 1Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 91Cisplatin 69Oxaliplatin 37Capecitabine 37durvalumab 29Fluorouracil 26pembrolizumab 24Leucovorin 22S 1 (combination) 18Nivolumab 13Irinotecan 13lenvatinib 12Bevacizumab 11tremelimumab 10apatinib 8Trastuzumab 7Injections 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7Paclitaxel 6Immune Checkpoint Inhibitors 6Docetaxel 6titanium silicide 5surufatinib 5envafolimab 5camrelizumab 5atezolizumab 5Folfox protocol 5Drug Therapy 5Carboplatin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Biliary Tract Neoplasms × Actigraphy × Clear all
NCT07608458 2026-05-27

Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy

City of Hope Medical Center

Phase NA Not yet recruiting
70 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡